Items tagged with Access
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits (post with simple image)
Access to TB drug bedaquiline, a backbone medicine for drug-resistant TB treatment regimens, remains out of reach for too many.
WHO releases first-ever Standard on universal access to rapid TB diagnostics (post with simple image)
The Standard sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics, increase bacteriologically confirmed TB and drug resistance detection, and reduce the time to diagnosis.
Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV (post with simple image)
Advocates demand that Johnson & Johnson commit to non-enforcement of secondary patent on bedaquiline so that access to generic, quality-assured bedaquiline is guaranteed after the primary patent expires on 18 July 2023.
Global Drug Facility update on access to bedaquiline (post with simple image)
Global Drug Facility announces an agreement with Johnson & Johnson for access to affordable generic versions of bedaquiline; Treatment Action Group, Médecins Sans Frontières and Partners in Health release statements in response to the agreement.
Open letter to Johnson & Johnson requesting clarification on the recent deal on generic bedaquiline supply (post with simple image)
Advocates call for clarity on the terms of the Johnson & Johnson's deal with the Stop TB Partnership’s Global Drug Facility to supply generic bedaquiline.
Global Drug Facility announces price reductions up to 55% for bedaquiline (post with simple image)
The new prices are valid through December 2024 and present price reductions up to 55% compared to the previous price of US$289 for a 6-month treatment course of bedaquiline.
Johnson & Johnson and Cepheid must expand access to TB drug and tests (post with simple image)
TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools.
Reduced price and increased access to Cepheid’s TB test (post with simple image)
Global Fund, Stop TB Partnership and USAID announce new collaboration with Danaher to reduce price and increase access to Cepheid’s TB test. Five million additional tests can be procured with this lower price.
At this week’s UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign calls on political leaders to take urgent action for equitable access to shorter, safer TB regimens (post with simple image)
Ahead of the UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign is sounding the alarm that the political declaration commits neither the funding nor the actions needed to expand access to the best-available TB regimens and diagnostics.
TB preventive therapy price cut (post with simple image)
USAID and PEPFAR announce that they have secured a 30% price reduction on the TB preventive treatment regimen called 3HP, taking the price from $14.25 to $9.99 for a three-month patient course.
Page 80 of 83 · Total posts: 0
←First 79 80 81 Last→